Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response
Xiaohui Shen, Yuchen Zhang, Zhuoqing Xu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Organoids: The current status and biomedical applications
Siqi Yang, Hai‐Jie Hu, Heng‐Chung Kung, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 106
Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment
Mobina Bayat, Javid Sadri Nahand
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 10
Increased keratin 80 expression predicts poor prognosis and promotes oxaliplatin resistance in gastric cancer
Bo Yang, Hongxia Cao, Yulong He, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 12
Closed Access | Times Cited: 1
Applications of human organoids in the personalized treatment for digestive diseases
Qinying Wang, Fanying Guo, Yutao Jin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer
Zhaoliang Yu, Peng Deng, Yufeng Chen, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 6
Open Access | Times Cited: 6
Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
Yu Gan, M Kellis, Shuangze Han, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 241-241
Open Access | Times Cited: 13
Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer
Haoran Jiang, Yuan Zeng, Xue Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167210-167210
Closed Access | Times Cited: 4
Targeting cancer drug resistance utilizing organoid technology
Changpeng Chai, Pengfei Ji, Hao Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114098-114098
Open Access | Times Cited: 18
ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling
Jing Zhang, Xia Gu, Tian-Le Cheng, et al.
Circulation Research (2025)
Closed Access
Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Martina Taglieri, Linda Di Gregorio, Serena Matis, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 457-457
Open Access
The E3 ligase HUWE1 increases the sensitivity of CRC to oxaliplatin through TOMM20 degradation
Chanhaeng Lee, Sanghee Park, Sungjoo Kim Yoon
Oncogene (2024) Vol. 43, Iss. 9, pp. 636-649
Closed Access | Times Cited: 3
SWI/SNF Complex in Vascular Smooth Muscle Cells and Its Implications in Cardiovascular Pathologies
Hongyu Liu, Yang Zhao, Guizhen Zhao, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 168-168
Open Access | Times Cited: 3
Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320
M. Girod, Anja Geisler, Luisa Hinze, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5618-5618
Open Access | Times Cited: 3
PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1
Ming Yuan, Chi Zhang, Shaopeng Chen, et al.
Cancer Letters (2024) Vol. 597, pp. 217007-217007
Open Access | Times Cited: 3
Krüppel-like Factors 4 and 5 in Colorectal Tumorigenesis
Esther Lee, Jacky Cheung, Agnieszka B. Bialkowska
Cancers (2023) Vol. 15, Iss. 9, pp. 2430-2430
Open Access | Times Cited: 8
A proof-of-concept assay for quantitative and optical assessment of drug-induced toxicity in renal organoids
Jasmin Dilz, Isabel Auge, Kathrin Groeneveld, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Exploring the dual role of circRNA and PI3K/AKT pathway in tumors of the digestive system
Penghui Li, Di Huang, Xinyu Gu
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115694-115694
Open Access | Times Cited: 7
Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges
Jingwei Li, Jianhua Liu, Wuzheng Xia, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 2
Discovery of the Next-Generation Platinum-Based Anticancer Agents for Combating Oxaliplatin-Induced Drug Resistance
Ziru Sun, Jianbin Han, Jun Xu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10190-10210
Closed Access | Times Cited: 2
KLF5 inhibition initiates epithelial-mesenchymal transition in non-transformed human squamous epithelial cells
Dharmendra Bhargava, David Rusakow, Wilson Zheng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 7, pp. 119789-119789
Closed Access | Times Cited: 2
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Valentin Benboubker, George M. Ramzy, S. Jacobs, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
NEDD4L affects KLF5 stability through ubiquitination to control ferroptosis and radiotherapy resistance in oesophageal squamous cell carcinoma
Jinjin Chen, Kaijun Ying, Jian Sun, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 18
Open Access | Times Cited: 2
Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription
Qi Zuo, Qimei Xu, Zhen Li, et al.
Anti-Cancer Drugs (2023)
Closed Access | Times Cited: 5
Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer
Denise van der Graaff, Sofie Seghers, Pieterjan Vanclooster, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2671-2671
Open Access | Times Cited: 1
Characterizing the effects of triclosan and triclocarban on the intestinal epithelial homeostasis using small intestinal organoids
Xiao‐Wen Cheng, Hongzhi Shen, Wen Zhang, et al.
Journal of Hazardous Materials (2024) Vol. 479, pp. 135734-135734
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top